mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.089 |
0.05 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |